Material Agreements

JAKKS PACIFIC INC entered into Redemption Agreement with holders of its Series A Senior Preferred Stock valued at $35 million (effective 2024-03-08).

“On March 8, 2024, the registrant entered into a Redemption Agreement (the “Redemption Agreement”) with the holders of its Series A Senior Preferred Stock (the “Preferred Stock”). Pursuant to the terms of the Redemption Agreement, the Company redeemed all outstanding shares of the Preferred Stock for an aggregate purchase price of $35 million, consisting of $20 million of cash and 571,295 shares of its common stock ( the “Common Stock”), valued at $15 million, or $26.26 per share.”

Coterra Energy Inc. entered into Second Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $500,000,000 aggregate principal amount (effective 2024-03-13).

“closed its previously announced registered public offering of $500,000,000 aggregate principal amount of its 5.60% senior notes due 2034”

UMH PROPERTIES, INC. entered into Distribution Agreement with BMO Capital Markets Corp., J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, B. Riley Securities, Inc., Compass Point Research & Trading, LLC, and Janney Montgomery Scott LLC valued at $150,000,000 (effective 2024-03-12).

“(the “Company”) entered into an equity distribution agreement (the “Distribution Agreement”) with BMO Capital Markets Corp., J.P.”

KORU Medical Systems, Inc. entered into Loan and Security Agreement with HSBC Ventures USA Inc. valued at $5,000,000 (effective 2024-03-08).

“On March 8, 2024, KORU Medical Systems, Inc. (the “Company”) entered into a loan and security agreement (the “Loan and Security Agreement”), by and between the Company and HSBC Ventures USA Inc., as lender providing for a revolving credit facility in an aggregate principal amount not to exceed $5,000,000 (the “Revolver”) and a term loan facility in an aggregate principal amount not to exceed $5,000,000”

HUMANA INC entered into Twenty-Ninth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2024-03-13).

“and a twenty-ninth supplemental indenture, dated as of March 13, 2024, by and between the Company and the Trustee relating to the 2054 Senior Notes (the “Twenty-Ninth Supplemental Indenture””

HUMANA INC entered into Twenty-Eighth Supplemental Indenture with The Bank of New York Mellon Trust Company, N.A. (effective 2024-03-13).

“The Senior Notes were issued under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the “Trustee”) (the “Original Indenture”), as supplemented by a twenty-eighth supplemental indenture, dated as of March 13, 2024, by and between the Company and the Trustee relating to the 2031 Senior Notes (the “Twenty-Eighth Supplemental Indenture””

HUMANA INC entered into Underwriting Agreement with Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC and Wells Fargo Securities, LLC valued at $1,250 million aggregate principal amount of its 5.375% Senior Notes due 2031 and $1,000 million agg (effective 2024-03-11).

“On March 11, 2024, Humana Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC and Wells Fargo Securities, LLC , as representatives of the several underwriters (together, the “Underwriters”), pursuant to which the Company agreed to issue and sell to the Underwriters $1,250 million aggregate principal amount of its 5.375% Senior Notes due 2031 (the “2031 Senior Notes”) and $1,000 million aggregate principal amount of its 5.750% Senior Notes due 2054 (the “2054 Senior Notes” and, together with the 2031 Senior Notes, the “Senior Notes”), in accordance with the terms and conditions set forth in the Underwriting Agreement.”

T. Rowe Price OHA Select Private Credit Fund entered into Master Note Purchase Agreement with qualified institutional investors valued at $300,000,000 in aggregate principal amount of Series 2024A Senior Notes, due March 7, 2029, with a f (effective 2024-03-07).

“On March 7, 2024, T. Rowe Price OHA Select Private Credit Fund (the “Company”) entered into a Master Note Purchase Agreement (the “Note Purchase Agreement”) governing the issuance of $ 300,000,000 in aggregate principal amount of Series 2024A Senior Notes, due March 7, 2029, with a fixed interest rate of 7.77% per year (the “Notes”), to qualified institutional investors in a private placement.”

Corebridge Financial, Inc. entered into Amendment and Waiver of Consent and Voting Rights with American International Group, Inc. valued at Amendment and Waiver of Consent and Voting Rights (effective 2024-03-11).

“On March 11, 2024, Corebridge Financial, Inc. (the “Company”) entered into an Amendment and Waiver of Consent and Voting Rights (the “Amendment and Waiver”) with American International Group, Inc. (“AIG”) and certain affiliates of Argon Holdco LLC (“Argon”) and Blackstone, Inc. (“Blackstone”) that (i) amends the Stockholders Agreement, dated as of November 2, 2021, between the Company, AIG and Argon such that Argon shall have no right to consent to any repurchase of shares of common stock of the Company, par value $0.01 per share (“Common Stock”) if such repurchase would result in Argon owning, of record, more than 9.9% of the then-outstanding Common Stock, provided that , no such repurchase will be permitted if it would result in Argon owning, of record, more than 14.9% of the then-outstanding Common Stock and (ii) waives the right of Argon, Blackstone and certain of their affiliates to vote or act by written consent with respect to any shares of Common Stock owned by them from time t”

MAIA Biotechnology, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at approximately $2.4 million (effective 2024-03-11).

“On March 11, 2024, MAIA Biotechnology, Inc. (the " Company ") entered into a Securities Purchase Agreement (the " Purchase Agreement ") with certain accredited investors (the " Investors ") for the issuance and sale in a private placement (the " Private Placement ") of (i) 2,043,587 shares (the "Investor Shares") of the Company’s common stock, par value $0.0001 per share (" Common Stock "), and (ii) warrants (the " Investor Warrants ") to purchase up to 2,043,587 shares of the Company’s Common Stock, at a price per share of $1.17 for an aggregate purchase price of approximately $2.4 million.”

Bite Acquisition Corp. amended Business Combination Agreement with Above Food Corp. (effective 2024-03-12).

“On March 12, 2024, Bite, Above Food, TopCo and Merger Sub entered into an amendment to the Business Combination Agreement ("Amendment No. 1")”

Renalytix plc entered into Placing Agreement with Stifel Nicolaus Europe Limited valued at up to an aggregate of 46,801,872 ordinary shares (effective 2024-03-12).

“On March 12, 2024, Renalytix plc (the “ Company ”) entered into a Placing Agreement (the “ Placing Agreement ”) with Stifel Nicolaus Europe Limited (the “ Bookrunner ” or “ Stifel ”), pursuant to which the Company agreed to allot and issue new ordinary shares, nominal value £0.0025 per ordinary share (the “ Placing Shares ”) to certain investors (the “ Placees ”) in an unregistered offering (the “ Private Placement ”), up to an aggregate of 46,801,872 ordinary shares.”

BTC Digital Ltd. entered into Acquisition Agreement with Alpha Plotter, LLC valued at $3.4 million (effective 2024-03-09).

“On March 9, 2024, and Meten Service USA Corp. (“Meten”), a wholly owned subsidiary of BTC Digital Ltd. (the “Company”), entered into an acquisition and purchase agreement (the “Acquisition Agreement”) with Alpha Plotter, LLC (the “Seller”) to acquire the Seller’s BTC mining facility under construction in North Carolina (the “Facility”).”

John Deere Receivables LLC entered into Underwriting Agreement with the underwriters valued at Underwriting Agreement for asset-backed securities issued by John Deere Owner Trust 2024 (effective 2024-03-11).

“Item 1.01 Entry into a Material Definitive Agreement . In connection with the issuance by John Deere Owner Trust 2024 (the “ Trust ” ) of the asset-backed securities (the “ Notes ” ) described in the Prospectus, dated March 11, 2024 (the “ Prospectus ” ), which was filed with the Securities and Exchange Commission pursuant to its Rule 424(b)(5) by John Deere Receivables LLC (the “ Registrant ” or the “ Depositor ” ), the Depositor entered into an Underwriting Agreement on March 11, 2024 (the “ Underwriting Agreement ” ) with the underwriters listed in”

INTELLIGENT BIO SOLUTIONS INC. entered into Securities Purchase Agreement with several institutional and accredited investors (effective 2024-03-08).

“On March 8, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with several institutional and accredited investors”

Synchrony Card Funding, LLC entered into Class A(2024-1) Underwriting Agreement with Wells Fargo Securities, LLC, Barclays Capital Inc. and SG Americas Securities, LLC (effective 2024-03-11).

“On March 11, 2024, Synchrony Card Funding, LLC (“ Funding ”) and Synchrony Bank entered into an Underwriting Agreement by and among Funding, Synchrony Bank, Wells Fargo Securities, LLC, Barclays Capital Inc. and SG Americas Securities, LLC (the “ Class A(2024-1) Underwriting Agreement ”)”

Limbach Holdings, Inc. amended First Amendment to the Second A&R Wintrust Credit Agreement with Wheaton Bank & Trust Company, N.A., a subsidiary of Wintrust Financial Corporation (effective 2024-03-13).

“On March 13, 2024, Limbach Facility Services LLC, Limbach Holdings LLC and other designated loan parties entered into a first amendment to the second amended and restated Wintrust credit agreement (the “First Amendment to the Second A&R Wintrust Credit Agreement”) with the lenders party thereto and Wheaton Bank & Trust Company, N.A., a subsidiary of Wintrust Financial Corporation (collectively, “Wintrust”), as administrative agent.”

Evolus, Inc. entered into Underwriting Agreement with Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated as representatives of the underwriters named in Schedule A valued at approximately $46.9 million (effective 2024-03-11).

“On March 11, 2024, Evolus, Inc., a Delaware corporation (the “Company”), entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners, LLC and Stifel, Nicolaus & Company, Incorporated as representatives of the underwriters named in Schedule A thereto (together, the “Underwriters”), in connection with the underwritten public offering, issuance and sale by the Company (the “Offering”) of 3,554,000 shares (the “Firm Shares”) of the Company’s common stock, par value $0.00001 per share (the “Common Stock”).”

Delek Logistics Partners, LP entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $650,000,000 (effective 2024-03-13).

“On March 13, 2024, Delek Logistics Partners, LP, a Delaware limited partnership (the “Partnership”), Delek Logistics Finance Corp., a Delaware corporation and a wholly owned subsidiary of the Partnership (“Finance Corp.” and together with the Partnership, the “Issuers”), the Partnership’s existing subsidiaries (other than Finance Corp., the “Guarantors”) and U.S. Bank Trust Company, National Association, as trustee, entered into an indenture (the “Indenture”), pursuant to which the Issuers issued $650,000,000 in aggregate principal amount of 8.625% senior notes due 2029 (the “2029 Notes”).”

Empire State Realty Trust, Inc. amended Third Amendment to that certain Credit Agreement, dated as of March 19, 2020 with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto (effective 2024-03-13).

“On March 13, 2024, the Operating Partnership and the Company entered into a Third Amendment to that certain Credit Agreement, dated as of March 19, 2020 (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “ WF Credit Agreement ”) among the Company, the Operating Partnership, the lenders party thereto from time to time and Wells Fargo Bank, National Association, as administrative agent.”

Empire State Realty Trust, Inc. amended Second Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent, Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as co-syndication agents, and the lenders and the letter of credit issuers party thereto valued at $620 million senior unsecured revolving credit facility and a $95 million term loan facility (effective 2024-03-08).

“On March 8, 2024, Empire State Realty OP, L.P. (the “ Operating Partnershi p”) and its general partner, Empire State Realty Trust, Inc. (the “ Company ”) entered into a Second Amended and Restated Credit Agreement (the “ BofA Credit Agreement ”) with Bank of America, N.A., as administrative agent, Wells Fargo Bank, National Association and JPMorgan Chase Bank, N.A., as co-syndication agents, and the lenders and the letter of credit issuers party thereto.”

Skye Bioscience, Inc. amended Amendment with certain investors (effective 2024-03-11).

“Concurrently and in connection with the Private Placement, the Company entered into an amendment (the “Amendment”) to the warrants issued pursuant to that certain Securities Purchase Agreement, dated August 15, 2023, by and between the Company and certain investors (the “2023 PIPE Warrants”).”

Skye Bioscience, Inc. entered into Registration Rights Agreement with the Investors (effective 2024-03-11).

“On March 11 , 2024, concurrently and in connection with the execution of the Purchase Agreement, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with the Investors, pursuant to which the Investors will have certain customary registration rights, and the Company will be required to prepare and file a resale registration statement (the “Registration Statement”) with the SEC to register the resale of the Shares and the Warrant Shares within 60 days after the date of the Registration Rights Agreement (the “Filing Date”), and to use reasonable best efforts to have the Registration Statement declared effective as promptly as possible thereafter, and in any event no later than 30 days following the Filing Date (or 60 days following the Filing Date in the event the SEC reviews and has written comments to the Registration Statement).”

Skye Bioscience, Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $40,000,000 (effective 2024-03-11).

“On March 11 , 2024, Skye Bioscience, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (collectively, the “Investors”) to issue and sell at closing an aggregate of 4,000,000 shares (the “Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”), at a price of $ 10.00 per Share (the "Private Placement").”

BlueOne Card, Inc. entered into Master Program Manager Services Agreement with a third-party bank (effective 2024-02-27).

“On March 5, 2024, the Board of Directors of BlueOne Card, Inc., a Nevada corporation (the “ Company ”), approved and ratified the Company entering into the Master Program Manager Services Agreement dated February 27, 2024 (the “ Agreement ”) with a third-party bank (the “ Bank ”).”

Scorpius Holdings, Inc. amended Amendment No. 7 with Continental Stock Transfer & Trust Company (effective 2024-03-11).

“On March 11, 2024, Scorpius Holdings, Inc. (formerly known as NightHawk Biosciences, Inc.) (the “Company”) entered into Amendment No. 7 (“Amendment No. 7”) dated March 11, 2024 to the Rights Agreement dated March 11, 2018 (the “Original Rights Agreement”), as amended by Amendment No. 1 thereto (“Amendment No. 1”) dated March 8, 2019, Amendment No. 2 thereto (“Amendment No. 2”) dated March 10, 2020, Amendment No. 3 thereto (“Amendment No. 3”) dated March 8, 2021, Amendment No. 4 thereto (“Amendment No. 4”) dated March 11, 2022, Amendment No. 5 thereto (“Amendment No. 5”) dated March 11, 2023, and Amendment No. 6 thereto (“Amendment No. 6”) dated December 11, 2023 (collectively, the “Rights Agreement”) by and between the Company and Continental Stock Transfer & Trust Company, as rights agent.”

ESPORTS ENTERTAINMENT GROUP, INC. entered into Secured Note Purchase Agreement with the holder of Series C Convertible Preferred Stock and Series D Convertible Preferred Stock valued at approximately $1.42 million (effective 2024-03-07).

“On March 13, 2024, Esports Entertainment Group, Inc. (the “Company”) announced that it entered into an agreement, dated March 7, 2024 (the “Secured Note Purchase Agreement”) with the holder (the “Holder”) of its Series C Convertible Preferred Stock (“Series C Preferred Stock”) and Series D Convertible Preferred Stock (the “Series D Preferred Stock”), pursuant to which the Company issued the Holder a secured promissory note (the “Secured Note”), for approximately $1.42 million in cash and certain amendments to the terms of the Series C Preferred Stock and Series D Preferred Stock.”

COGNITION THERAPEUTICS INC entered into Underwriting Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2024-03-11).

“On March 11, 2024, Cognition Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC (the “Underwriter”), pursuant to which the Company agreed to issue and sell to the Underwriter, in a public offering (the “Offering”), 6,571,428 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”) at a public offering price of $1.75 per share (the “Offering Price”).”

HYUNDAI ABS FUNDING LLC entered into Underwriting Agreement with Hyundai Capital America and BofA Securities, Inc., on its own behalf and as representative of the several underwriters valued at $1,647,010,000 (effective 2024-03-11).

“On March 11, 2024, Hyundai ABS Funding, LLC (“HABS”), Hyundai Capital America (“HCA”) and BofA Securities, Inc., on its own behalf and as representative of the several underwriters (the “Underwriters”) entered into an Underwriting Agreement, pursuant to which notes in the following classes: Class A-1, Class A-2-A, Class A-2-B, Class A-3, Class A-4, Class B and Class C Asset Backed Notes (collectively, the “Notes”) with an aggregate principal balance of $1,647,010,000 were sold to the Underwriters.”

APPLIED OPTOELECTRONICS, INC. entered into Equity Distribution Agreement with Raymond James & Associates, Inc. valued at up to $25 million (effective 2024-03-13).

“On March 13, 2024, Applied Optoelectronics, Inc. (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Raymond James & Associates, Inc. (the “Sales Agent”) pursuant to which the Company may issue and sell shares of the Company’s common stock, par value $0.001 per share (the “Shares”) having an aggregate offering price of up to $25 million from time to time through the Sales Agent.”

IMPINJ INC entered into Settlement and Patent Cross-License Agreement with NXP Semiconductors N.V. and its subsidiary NXP USA, Inc. valued at $45.0 million one-time payment plus annual license fee payments starting at $15.0 million increasing (effective 2024-03-13).

“On March 13, 2024, Impinj, Inc. (“Impinj”) and NXP Semiconductors N.V. and its subsidiary NXP USA, Inc. (collectively, “NXP”) entered into a Settlement and Patent Cross-License Agreement dated March 13, 2024 (the “Agreement”), which resolves all outstanding litigation and other proceedings between them.”

RED RIVER BANCSHARES INC entered into Stock Repurchase Agreement with Angela Katherine Simpson Irrevocable Trust UA 25-NOV-03 and John Charles Simpson Jr. Irrevocable Trust UA 25-NOV-03 valued at 200,000 shares of common stock for $10,000,000 (approximately $50.00 per share) (effective 2024-03-13).

“On March 13, 2024, Red River Bancshares, Inc. (the “Company”) entered into a stock repurchase agreement (the “Stock Repurchase Agreement”) with the Angela Katherine Simpson Irrevocable Trust UA 25-NOV-03 and the John Charles Simpson Jr. Irrevocable Trust UA 25-NOV-03 (the “Stockholders”) for the purchase by the Company of 200,000 shares of the Company’s common stock, no par value per share (the “Common Stock”) from the Stockholders in a privately-negotiated transaction for a total purchase price of approximately $10.0 million.”

Hyperscale Data, Inc. entered into Note Purchase Agreement with two institutional investors valued at $2,000,000 principal face amount convertible promissory notes, purchase price $1,800,000, 6% interes (effective 2024-03-11).

“On March 11, 2024 (the “ Effective Date ”), Ault Alliance, Inc. (the “ Company ”) entered into a note purchase agreement (the “ Purchase Agreement ”) with two institutional investors (the “ Investors ”) pursuant to which the Investors agreed, severally and not jointly, to acquire, and the Company agreed to issue and sell in a registered direct offering to the Investors (the “ Offering ”), an aggregate of $2,000,000 principal face amount convertible promissory notes (the “ Notes ”), subject to customary closing conditions.”

SCHOLASTIC CORP entered into Securities Purchase Agreement with Niagara Investments, Ltd., ZMC Niagara Investment (Canada), Ltd., ZMC Niagara Investment (Cayman), L.P., Fansea Investments Ltd., UXL Investment Management Corporation, Commisso Trust, Vince Commisso, 2424886 Ontario Limited, Moon Shadow Inc., Jarosz Trust, Steven Jarosz, Tzia Limited, Natalie Osbor valued at CAD 250 million (approximately $186 million at current exchange rate) (effective 2024-03-11).

“On March 11, 2024, Scholastic Corporation (the “ Company ”) through 1000815816 Ontario Inc., a corporation organized and existing under the corporate laws of the Province of Ontario, Canada (the “ Purchaser ”), entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) to acquire, indirectly, all of the economic interests in the form of non-voting shares and 25% of the voting shares in 9 Story Media Group Inc.”

EDUCATIONAL DEVELOPMENT CORP entered into Letter of Intent with Blue Ledge Group valued at $37,750,000 (effective 2024-03-06).

“Effective March 6, 2024, Educational Development Corporation (“EDC”, the “Company” or “Seller”) entered into a Letter of Intent with Blue Ledge Group (“Buyer”) to execute a Purchase and Sale Agreement for the Company’s headquarters and distribution warehouse”

Cadrenal Therapeutics, Inc. entered into At the Market Offering Agreement with H.C. Wainwright & Co., LLC valued at $5,143,730 (effective 2024-03-11).

“On March 11, 2024, Cadrenal Therapeutics, Inc., a Delaware corporation, (the “Company”), entered into an At the Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent to sell shares of the Company’s common stock”

Real Good Food Company, Inc. amended Amendment with PMC Financial Services Group, LLC valued at $45.0 million (effective 2024-03-07).

“On March 7, 2024, Real Good Foods, LLC, a wholly owned subsidiary of The Real Good Food Company, Inc. (the “Company”), entered into an amendment (the “Amendment”) to its amended and restated Loan and Security Agreement with PMC Financial Services Group, LLC (“PMC”), dated June 30, 2016 (the “Existing Credit Facility”).”

Zeo Energy Corp. entered into Non-Redemption Agreement with The K2 Principal Fund L.P. (effective 2024-03-11).

“On March 11, 2024, ESGEN Acquisition Corporation, a Cayman Islands exempted company incorporated with limited liability (“ESGEN”), entered into a non-redemption agreement (the “Non-Redemption Agreement”) with The K2 Principal Fund L.P. (“K2”)”

Lucy Scientific Discovery, Inc. terminated Amalgamation Agreement with Bluesky Biologicals Inc. (effective 2024-03-05).

“nd Bluesky Biologicals Inc., a corporation existing under the laws of the Province of British Columbia (“ Bluesky ” or “ Acquiree ”), entered into that certain Amalgamation Agreement (the “ Agreement ”), pursuant to”

Sovos Brands, Inc. terminated Credit Agreement with the financial institutions party thereto and Credit Suisse AG, Cayman Islands Branch, as Administrative Agent (effective 2024-03-12).

“Item 1.02. Termination of a Material Definitive Agreement. In connection with the consummation of the Merger (defined below), on March 12, 2024, the Company repaid in full all outstanding amounts under the First Lien Credit Agreement, dated as of June 8, 2021, as amended by that certain Amendment No. 1, dated June 28, 2023, by and among Sovos Brands Intermediate, Inc., Sovos Brands Holdings, Inc., the financial institutions party thereto and Credit Suisse AG, Cayman Islands Branch, as Administrative Agent, and all financing-related documents (the “ Credit Agreement ”), and terminated the Credit Agreement and all commitments by the lenders to extend further credit thereunder.”

Sovos Brands, Inc. entered into Merger Agreement with Campbell Soup Company and Premium Products Merger Sub, Inc. (effective 2024-03-12).

“er Agreement ”), by and among Sovos Brands, Inc. (the “ Company ”), Campbell Soup Company (“ Campbell ”) and Premium Products Merger Sub, Inc., a wholly-owned subsidiary of Campbell (“ Merger Sub ”).”

ExcelFin Acquisition Corp. amended First Amendment to the Business Combination Agreement with Betters Medical Investment Holdings Limited valued at Amendment to business combination agreement, including changes to earnout shares, SPAC closing cash (effective 2024-03-11).

“(“ ExcelFin ”), Betters Medical Investment Holdings Limited (“ Betters ”), Baird Medical Investment Holdings Limited (“ PubCo ”), Betters Medical Merger Sub, Inc.”

Focus Impact BH3 Acquisition Co entered into Business Combination Agreement with XCF Global Capital, Inc. (effective 2024-03-11).

“On March 11, 2024, BHAC entered into a Business Combination Agreement (the “Business Combination Agreement”) with Focus Impact BH3 Newco, Inc.”

Bannix Acquisition Corp. amended Trust Amendment with Continental Stock Transfer & Trust Company (effective 2024-03-08).

“(the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”) entered into an amendment, dated March 8, 2024 (the “Trust Amendment”) to the Investment Management Trust Agreement, dated as of September 14, 2021,”

Bannix Acquisition Corp. terminated Business Combination Agreement with EVIE Autonomous Group Ltd. and the shareholder of the EVIE Group (effective 2024-03-11).

“On March 11, 2024, Bannix sent EVIE Group and the EVIE Group Shareholder a notice providing that the Business Combination Agreement has been terminated as a result of the failure of EVIE Group and the EVIE Group Shareholder to loan or procure a loan to Bannix as required pursuant to Section 5.21 of the Business Combination Agreement.”

Iris Acquisition Corp entered into Administrative Support Agreement with Arrow Capital Management LLC valued at $10,000 per month (effective 2024-03-11).

“On March 11, 2024, the Company entered into an administrative support agreement (the "Agreement") with Arrow Capital Management LLC ("Arrow").”

Iris Acquisition Corp amended Amended Note with Liminatus Pharma LLC valued at up to $2,500,000 (effective 2024-02-28).

“On February 28, 2024, the Company and the Payee amended and restated the Note (the "Amended Note"). The Amended Note increased the aggregate principal amount to up to $2,500,000, and added advances that occurred under the Note.”

Iris Acquisition Corp entered into Promissory Note with Liminatus Pharma LLC valued at up to $1,500,000 (effective 2023-10-04).

“On October 4, 2023, Iris Acquisition Corp, a Delaware corporation (the "Company") issued an unsecured promissory note in the aggregate principal amount up to $1,500,000 (the "Note") to Liminatus Pharma LLC (the "Payee").”

Li-Cycle Holdings Corp. entered into Note Purchase Agreement with Glencore Ltd. and Glencore Canada Corporation valued at $75,000,000 (effective 2024-03-11).

“On March 11, 2024, Li-Cycle Holdings Corp. (the “ Company ”) entered into a Note Purchase Agreement (the “ Note Purchase Agreement ”) with Glencore Ltd. (“ Glencore Intermediate ”), and Glencore Canada Corporation (“ Glencore ”, and together with Glencore Intermediate, the “ Glencore Parties ”), pursuant to which the Company agreed to issue and sell to Glencore a senior secured convertible note (the “ Senior Secured Convertible Note ”) in an aggregate principal amount of $75,000,000”

Mondee Holdings, Inc. amended Amendment No. 13 with TCW Asset Management Company, Wingspire Capital LLC, and the lenders from time to time (effective 2024-03-11).

“On March 11, 2024, Mondee Holdings, Inc., a Delaware corporation (the “ Company ”), and certain of its subsidiaries, on the one hand, and TCW Asset Management Company, a Delaware limited liability company (the “ Administrative Agent ”), Wingspire Capital LLC, a Delaware limited liability company (“ Wingspire ”), and the lenders from time to time (the “ Lenders ”) party to the Financing Agreement (as defined herein), on the other hand, entered into that certain Amendment No. 13 (the “ Amendment ”) to that certain financing agreement, dated as of December 23, 2019”